Next Article in Journal
FOLFIRINOX in Patients With Peritoneal Carcinomatosis From Pancreatic Adenocarcinoma: A Retrospective Study
Previous Article in Journal
Exploring Reasons for Overuse of Contralateral Prophylactic Mastectomy in Canada
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Current Oncology
Volume 26
Issue 4
10.3747/co.26.4583
curroncol-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
Current Oncology is published by MDPI from Volume 28 Issue 1 (2021). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with Multimed Inc..
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

18f-Fluorodeoxyglucose Positron-Emission Tomography for the Investigation of Malignancy in Patients with Suspected Paraneoplastic Neurologic Syndromes and Negative or Indeterminate Conventional Imaging: A Retrospective Analysis of the Ontario Pet Access Program, with Systematic Review and Meta-Analysis

by
C. Harlos
1,*,
U. Metser
2,
R. Poon
3,
P. MacCrostie
4 and
W. Mason
5
1
Section of Hematology/Oncology, Department of Internal Medicine, Max Rady College of Medicine, University of Manitoba, and Department of Medical Oncology and Hematology, CancerCare Manitoba, Winnipeg, MB, Canada
2
Joint Department of Medical Imaging, Princess Margaret Cancer Centre, University Health Network, Mount Sinai Hospital and Women’s College Hospital, University of Toronto, Toronto, ON, Canada
3
Program in Evidence-Based Care, Cancer Care Ontario, Juravinski Hospital and Cancer Centre, Hamilton, ON, Canada
4
Cancer Imaging, Clinical Programs and Quality Initiatives, Cancer Care Ontario, Toronto, ON, Canada
5
Divisions of Neurology and Medical Oncology, Department of Medicine, University of Toronto, Princess Margaret Cancer Centre, Toronto, ON, Canada
*
Author to whom correspondence should be addressed.
Curr. Oncol. 2019, 26(4), 458-465; https://doi.org/10.3747/co.26.4583
Submission received: 1 May 2019 / Revised: 3 June 2019 / Accepted: 7 July 2019 / Published: 1 August 2019

Abstract

Objective: Paraneoplastic neurologic syndrome (pns) is a rare condition indirectly caused by an underlying malignancy. In many cases, the malignancy is occult at the time of the pns diagnosis, and the optimal diagnostic modality to detect the underlying tumour is unclear. In the present study, we aimed to assess the utility of 18F-fluorodeoxyglucose positron-emission tomography (fdg-pet) or pet integrated with computed tomography (pet/ct) in the investigation of these patients. Methods: We retrospectively analyzed data from the PET Access Program (pap) database in the province of Ontario to identify patients who underwent fdg-pet/ct imaging as part of a workup for pns. In all patients, prior conventional imaging was negative or indeterminate. To determine the diagnostic accuracy of fdg-pet/ct, data about demographics, presenting symptoms, and biochemical and radiologic workup, including fdg-pet/ct imaging results, were compared with data collected by the Ontario Cancer Registry (ocr). A systematic review of the literature and meta-analysis using our study inclusion criteria were performed for studies of fdg-pet accuracy. Results: Of 29 patients identified in the pap database, 9 had fdg-pet/ct results suspicious for malignancy. When correlated with data from the ocr, 5 fdg-pet/ct results were informative, resulting in a detection rate of 17%. Local sensitivity and specificity were 0.83 and 0.83 respectively. Two studies meeting our criteria were identified in the literature. The pooled sensitivity and specificity from the literature and local data were 0.88 and 0.90 respectively. Conclusions: When investigating for underlying malignancy in patients with suspected pns and negative conventional imaging, pet has high sensitivity and specificity.
Keywords: paraneoplastic neurologic syndrome; positron-emission tomography; malignancy; sensitivity; specificity paraneoplastic neurologic syndrome; positron-emission tomography; malignancy; sensitivity; specificity

Share and Cite

MDPI and ACS Style

Harlos, C.; Metser, U.; Poon, R.; MacCrostie, P.; Mason, W. 18f-Fluorodeoxyglucose Positron-Emission Tomography for the Investigation of Malignancy in Patients with Suspected Paraneoplastic Neurologic Syndromes and Negative or Indeterminate Conventional Imaging: A Retrospective Analysis of the Ontario Pet Access Program, with Systematic Review and Meta-Analysis. Curr. Oncol. 2019, 26, 458-465. https://doi.org/10.3747/co.26.4583

AMA Style

Harlos C, Metser U, Poon R, MacCrostie P, Mason W. 18f-Fluorodeoxyglucose Positron-Emission Tomography for the Investigation of Malignancy in Patients with Suspected Paraneoplastic Neurologic Syndromes and Negative or Indeterminate Conventional Imaging: A Retrospective Analysis of the Ontario Pet Access Program, with Systematic Review and Meta-Analysis. Current Oncology. 2019; 26(4):458-465. https://doi.org/10.3747/co.26.4583

Chicago/Turabian Style

Harlos, C., U. Metser, R. Poon, P. MacCrostie, and W. Mason. 2019. "18f-Fluorodeoxyglucose Positron-Emission Tomography for the Investigation of Malignancy in Patients with Suspected Paraneoplastic Neurologic Syndromes and Negative or Indeterminate Conventional Imaging: A Retrospective Analysis of the Ontario Pet Access Program, with Systematic Review and Meta-Analysis" Current Oncology 26, no. 4: 458-465. https://doi.org/10.3747/co.26.4583

APA Style

Harlos, C., Metser, U., Poon, R., MacCrostie, P., & Mason, W. (2019). 18f-Fluorodeoxyglucose Positron-Emission Tomography for the Investigation of Malignancy in Patients with Suspected Paraneoplastic Neurologic Syndromes and Negative or Indeterminate Conventional Imaging: A Retrospective Analysis of the Ontario Pet Access Program, with Systematic Review and Meta-Analysis. Current Oncology, 26(4), 458-465. https://doi.org/10.3747/co.26.4583

Article Metrics

Back to TopTop